Patrick Meek, PharmD, MSPH
Education
- University of Wisconsin at Madison, M.S.P.H.
- University of Wisconsin Hospital and Clinics, Fellowship
- University of Cincinnati, Pharm.D.
- The Buffalo General Hospital, Residency
- State University of New York at Buffalo, B.S.
Courses Taught at ACPHS
- Drug Information
- Pathophysiology, Therapeutics, Pharmacology and Medicinal Chemistry (PTP&M) – GI/Nutrition
- Ambulatory Care clerkship in Gastroenterology/Hepatology (Advance Pharmacy Practice Experience)
- Drug Policy Development clerkship (Advance Pharmacy Practice Experience)
Research Grant
- Co-Principal Investigators: Meek PD, Rosenberg M. Patterns of Utilization of Infliximab and Impact on Direct Medical and Indirect Costs in Individuals Diagnosed with Inflammatory Bowel Disease. Society of Actuaries. August 2007.
Technical Reports
- Meek PD, Shah ND, Van Houten H, Gumustop B, Rosenberg M. Infliximab Therapy for Individuals with Crohn's Disease: Analysis of Health Care Utilization and Expenditures. [Online] 29 January 2009.
Textbook Chapters
- Meek PD, Renaud-Mutart AC, Cosler LE. Chapter 14. Comparative Effectiveness. Health Economics and Outcomes Assessment. 1st edt. Sudbury, MA: Jones and Bartlett Publishers.
- Meek PD. Recent Concepts in the Treatment of the Irritable Bowel Syndrome. Pharmacotherapy Self-assessment Program. 4th edt. Kansas City, MO: American College of Clinical Pharmacy, 2003:71-97.
- Meek PD, Steinkellner A. Chapter 5. Use and evaluation of Pharmaceoconomics from the payers’ perspective. Introduction to Applied Pharmacoeconomics. Edited by F. Randy Vogenberg 2000:81-108
Selected Publications and Abstracts